<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00681499</url>
  </required_header>
  <id_info>
    <org_study_id>KEK 18/08</org_study_id>
    <nct_id>NCT00681499</nct_id>
  </id_info>
  <brief_title>Quality of Life After Liver Resection</brief_title>
  <official_title>Long-term Evaluation of the Quality of Life After Major Hepatic Resection for Malignant and Benign Diseases.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Bern</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Bern</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients with malignant diseases are increasingly receiving more extensive hepatic
      resections, with im-proved preoperative and postoperative care leading to a reduced
      postoperative morbidity and mortality. In this setting, postoperative quality of life may
      become as important as overall patient survival. In this study we will be investigating the
      effect of the initial disease for which hepatic resection was carried out on short- and
      long-term quality of life.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background: Due to advances in operative methods and perioperative care, mortality and
      morbidity following major hepatic resection have decreased substantially, making long-term
      quality of life (QoL) an increasingly prominent issue.

      Objectives: We plan on evaluating whether postoperative diagnosis is associated with
      long-term QoL and health in patients who require hepatic surgery for benign or malignant
      diseases and how QoL evolves with time.

      Method: QoL will be evaluated using the European Organization for Research and Treatment of
      Cancer Quality of Life Questionnaire Core-30 and the liver-specific QLQ-LMC21 module. All
      patients requiring hepatic surgery aged &gt;18 years will be included in the study. QoL
      evaluation is carried out preoperatively and at set intervals postoperatively.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2008</start_date>
  <completion_date type="Actual">January 2014</completion_date>
  <primary_completion_date type="Actual">January 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Quality of Life</measure>
    <time_frame>preoperatively, 1-,3-,6-,12 months postoperatively</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">198</enrollment>
  <condition>Liver Diseases</condition>
  <condition>Liver Neoplasms</condition>
  <arm_group>
    <arm_group_label>malignant</arm_group_label>
    <description>eg. hepatocellular carcinoma, colorectal liver metastases</description>
  </arm_group>
  <arm_group>
    <arm_group_label>benign</arm_group_label>
    <description>eg. liver cysts, traumatic liver injuries, adenoma etc</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        All patients requiring liver resection for any benign or malignant liver diseases,
        including secondary tumours
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with planned liver resection

        Exclusion Criteria

          -  Patients with biopsy of the liver only

          -  Inability of understanding the questionnaire
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vanessa Banz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dep. of Visceral and transplant Surgery, University Hospital Berne, Switzerland</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of visceral and transplant surgery, Bern University Hospital</name>
      <address>
        <city>Bern</city>
        <zip>3010</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <reference>
    <citation>Cella DF. Quality of life: concepts and definition. J Pain Symptom Manage. 1994 Apr;9(3):186-92.</citation>
    <PMID>8014530</PMID>
  </reference>
  <reference>
    <citation>Slevin ML. Quality of life: philosophical question or clinical reality? BMJ. 1992 Aug 22;305(6851):466-9.</citation>
    <PMID>1392964</PMID>
  </reference>
  <reference>
    <citation>Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993 Mar 3;85(5):365-76.</citation>
    <PMID>8433390</PMID>
  </reference>
  <reference>
    <citation>Kavadas V, Blazeby JM, Conroy T, Sezer O, Holzner B, Koller M, Buckels J; EORTC Quality of Life Group. Development of an EORTC disease-specific quality of life questionnaire for use in patients with liver metastases from colorectal cancer. Eur J Cancer. 2003 Jun;39(9):1259-63. Review.</citation>
    <PMID>12763214</PMID>
  </reference>
  <reference>
    <citation>Sloan JA, Loprinzi CL, Kuross SA, Miser AW, O'Fallon JR, Mahoney MR, Heid IM, Bretscher ME, Vaught NL. Randomized comparison of four tools measuring overall quality of life in patients with advanced cancer. J Clin Oncol. 1998 Nov;16(11):3662-73.</citation>
    <PMID>9817289</PMID>
  </reference>
  <reference>
    <citation>Glimelius B, Hoffman K, Graf W, Påhlman L, Sjödén PO. Quality of life during chemotherapy in patients with symptomatic advanced colorectal cancer. The Nordic Gastrointestinal Tumor Adjuvant Therapy Group. Cancer. 1994 Feb 1;73(3):556-62.</citation>
    <PMID>8299077</PMID>
  </reference>
  <reference>
    <citation>Sterkenburg CA, King B, Woodward CA. A reliability and validity study of the McMaster Quality of Life Scale (MQLS) for a palliative population. J Palliat Care. 1996 Spring;12(1):18-25.</citation>
    <PMID>8857243</PMID>
  </reference>
  <reference>
    <citation>Brunelli C, Costantini M, Di Giulio P, Gallucci M, Fusco F, Miccinesi G, Paci E, Peruselli C, Morino P, Piazza M, Tamburini M, Toscani F. Quality-of-life evaluation: when do terminal cancer patients and health-care providers agree? J Pain Symptom Manage. 1998 Mar;15(3):151-8.</citation>
    <PMID>9564116</PMID>
  </reference>
  <reference>
    <citation>Tamames S, De Vega DS, Tamames S Jr. Surgical management of malignant tumors of the esophagogastric junction: a retrospective review of 188 patients. Int Surg. 1990 Apr-Jun;75(2):89-92.</citation>
    <PMID>2379996</PMID>
  </reference>
  <reference>
    <citation>Martin RC, Eid S, Scoggins CR, McMasters KM. Health-related quality of life: return to baseline after major and minor liver resection. Surgery. 2007 Nov;142(5):676-84.</citation>
    <PMID>17981187</PMID>
  </reference>
  <reference>
    <citation>Chen L, Liu Y, Li GG, Tao SF, Xu Y, Tian H. Quality of life in patients with liver cancer after operation: a 2-year follow-up study. Hepatobiliary Pancreat Dis Int. 2004 Nov;3(4):530-3.</citation>
    <PMID>15567739</PMID>
  </reference>
  <verification_date>November 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 19, 2008</study_first_submitted>
  <study_first_submitted_qc>May 19, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 21, 2008</study_first_posted>
  <last_update_submitted>November 12, 2015</last_update_submitted>
  <last_update_submitted_qc>November 12, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 13, 2015</last_update_posted>
  <responsible_party>
    <name_title>Vanessa Banz, MD</name_title>
    <organization>Dep. of Visceral and Transplant surgery, Bern University Hospital, Switzerland</organization>
  </responsible_party>
  <keyword>Quality of Life</keyword>
  <keyword>Liver Neoplasms</keyword>
  <keyword>Surgical procedures, Operative</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Diseases</mesh_term>
    <mesh_term>Liver Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

